Overview of Life Sciences AI Agents

Life Sciences AI Agents provides centralized trial planning in a single, intelligent platform that eliminates redundant manual tasks, connects operational and clinical data, and provides AI-driven insights, risk scoring, and real-time monitoring to help you make faster, more confident decisions across the entire clinical trial lifecycle.

Life Sciences AI Agents unifies the processes from separate source Oracle Life Sciences applications, which enable you to complete most of your trial oversight and decision-making workflows within the application.

The source Oracle Life Sciences applications can include:

• Oracle Life Sciences Clinical One Cloud Service
• Clinical Trial Management System (CTMS)
• Oracle Life Sciences Site Activate
• Oracle Life Sciences Site Select
• Electronic Trial Master File (eTMF)

Use Life Sciences AI Agents for:

• Portfolio and trial health monitoring—Clinical operation leads and executives can view real-time portfolio health across studies, sites, and countries with AI agents highlighting emerging risks in enrollment, timelines, or quality metrics. AI-generated alerts and suggested actions enable proactive intervention and resource optimization across programs.
• Trial planning and startup—Study managers and clinical operations leads can generate trial plans from protocol inputs leveraging AI to extract key parameters, model timelines and budgets, rank countries and sites, and initiate activation workflows. This eliminates manual feasibility and planning work, accelerating study startup while ensuring plans remain aligned with enrollment and budget targets.

Note:

Life Sciences AI Agents does not perform calculations on clinical data using any proprietary algorithm. It aggregates data from connected source systems and applies standard, transparent analytics and rule-based logic to surface operational insights. Any AI-driven suggestions are based on non-proprietary reasoning patterns and do not alter or calculate clinical measurements.